• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在p53肿瘤抑制基因中表达乳腺特异性R270H突变的小鼠模拟了人类乳腺癌的发展。

Mice expressing a mammary gland-specific R270H mutation in the p53 tumor suppressor gene mimic human breast cancer development.

作者信息

Wijnhoven Susan W P, Zwart Edwin, Speksnijder Ewoud N, Beems Rudolf B, Olive Kenneth P, Tuveson David A, Jonkers Jos, Schaap Mirjam M, van den Berg Jolanda, Jacks Tyler, van Steeg Harry, de Vries Annemieke

机构信息

Laboratory of Toxicology, Pathology and Genetics, National Institute of Public Health and the Environment, Bilthoven, The Netherlands.

出版信息

Cancer Res. 2005 Sep 15;65(18):8166-73. doi: 10.1158/0008-5472.CAN-05-1650.

DOI:10.1158/0008-5472.CAN-05-1650
PMID:16166291
Abstract

The tumor suppressor gene p53 has an apparent role in breast tumor development in humans, as approximately 30% of sporadic tumors acquire p53 mutations and Li-Fraumeni syndrome patients carrying germ line p53 mutations frequently develop breast tumors at early age. In the present study, conditional expression of a targeted mutation is used to analyze the role of the human R273H tumor-associated hotspot mutation in p53 in mammary gland tumorigenesis. Heterozygous p53(R270H/+)WAPCre mice (with mammary gland-specific expression of the p53.R270H mutation, equivalent to human R273H, at physiologic levels) develop mammary tumors at high frequency, indicating that the R270H mutation predisposes for mammary gland tumor development and acts in a dominant-negative manner in early stages of tumorigenesis. Spontaneous tumor development in these mice is further accelerated by 7,12-dimethylbenz(a)anthracene (DMBA) treatment at young age. The majority of spontaneous and DMBA-induced carcinomas and sarcomas from p53(R270H/+)WAPCre mice is estrogen receptor alpha positive, and expression profiles of genes also implicated in human breast cancer appear similarly altered. As such, p53(R270H/+)WAPCre mice provide a well-suited model system to study the role of p53 in breast tumorigenesis and the responsiveness of mammary gland tumors to chemotherapeutics.

摘要

肿瘤抑制基因p53在人类乳腺肿瘤发生过程中具有明显作用,因为大约30%的散发性肿瘤会发生p53突变,而且携带p53种系突变的李-佛美尼综合征患者经常在早年就发生乳腺肿瘤。在本研究中,通过条件性表达靶向突变来分析p53中人类R273H肿瘤相关热点突变在乳腺肿瘤发生中的作用。杂合的p53(R270H/+)WAPCre小鼠(在生理水平下乳腺特异性表达p53.R270H突变,等同于人类R273H)高频发生乳腺肿瘤,这表明R270H突变易导致乳腺肿瘤发生,并在肿瘤发生的早期以显性负性方式起作用。幼年时用7,12-二甲基苯并(a)蒽(DMBA)处理可进一步加速这些小鼠的自发肿瘤发生。来自p53(R270H/+)WAPCre小鼠的大多数自发和DMBA诱导的癌和肉瘤雌激素受体α呈阳性,并且与人类乳腺癌相关的基因表达谱也出现类似改变。因此,p53(R270H/+)WAPCre小鼠提供了一个非常合适的模型系统,用于研究p53在乳腺肿瘤发生中的作用以及乳腺肿瘤对化疗药物的反应性。

相似文献

1
Mice expressing a mammary gland-specific R270H mutation in the p53 tumor suppressor gene mimic human breast cancer development.在p53肿瘤抑制基因中表达乳腺特异性R270H突变的小鼠模拟了人类乳腺癌的发展。
Cancer Res. 2005 Sep 15;65(18):8166-73. doi: 10.1158/0008-5472.CAN-05-1650.
2
Mammary gland-specific ablation of focal adhesion kinase reduces the incidence of p53-mediated mammary tumour formation.乳腺特异性敲除粘着斑激酶可降低 p53 介导的乳腺肿瘤形成的发生率。
Br J Cancer. 2014 May 27;110(11):2747-55. doi: 10.1038/bjc.2014.219. Epub 2014 May 8.
3
A transgenic mouse model for mammary carcinogenesis.一种用于乳腺癌发生的转基因小鼠模型。
Oncogene. 1998 Feb 26;16(8):997-1007. doi: 10.1038/sj.onc.1201621.
4
Targeted Pten deletion plus p53-R270H mutation in mouse mammary epithelium induces aggressive claudin-low and basal-like breast cancer.小鼠乳腺上皮细胞中靶向性Pten缺失加p53-R270H突变可诱导侵袭性的claudin低表达型和基底样乳腺癌。
Breast Cancer Res. 2016 Jan 19;18(1):9. doi: 10.1186/s13058-015-0668-y.
5
Somatic mutation of p53 leads to estrogen receptor alpha-positive and -negative mouse mammary tumors with high frequency of metastasis.p53的体细胞突变会导致雌激素受体α阳性和阴性的小鼠乳腺肿瘤,且转移频率很高。
Cancer Res. 2004 May 15;64(10):3525-32. doi: 10.1158/0008-5472.CAN-03-3524.
6
Bcl-2 expression delays mammary tumor development in dimethylbenz(a)anthracene-treated transgenic mice.Bcl-2表达延缓二甲基苯并(a)蒽处理的转基因小鼠的乳腺肿瘤发展。
Oncogene. 1999 Nov 11;18(47):6597-604. doi: 10.1038/sj.onc.1203099.
7
Mutant p53(R270H) gain of function phenotype in a mouse model for oncogene-induced mammary carcinogenesis.致癌基因诱导的乳腺癌发生小鼠模型中突变型p53(R270H)的功能获得性表型
Int J Cancer. 2008 Apr 15;122(8):1701-9. doi: 10.1002/ijc.23317.
8
Infrequent p53 mutations in 7,12-dimethylbenz[a]anthracene-induced mammary tumors in BALB/c and p53 hemizygous mice.在BALB/c和p53半合子小鼠中,7,12-二甲基苯并[a]蒽诱导的乳腺肿瘤中p53突变罕见。
Mol Carcinog. 1994 Mar;9(3):175-83. doi: 10.1002/mc.2940090309.
9
Delay of dimethylbenz[a]anthracene-induced mammary tumorigenesis in transgenic mice by apoptosis induced by an unusual mutant p53 protein.一种异常突变型p53蛋白诱导的细胞凋亡导致转基因小鼠中苯并[a]芘诱导的乳腺肿瘤发生延迟。
Mol Carcinog. 1995 Oct;14(2):75-83. doi: 10.1002/mc.2940140203.
10
Environmental carcinogens and p53 tumor-suppressor gene interactions in a transgenic mouse model for mammary carcinogenesis.用于乳腺癌发生的转基因小鼠模型中环境致癌物与p53肿瘤抑制基因的相互作用
Environ Mol Mutagen. 2002;39(2-3):178-83. doi: 10.1002/em.10064.

引用本文的文献

1
Is loss of p53 a driver of ductal carcinoma in situ progression?p53 缺失是否是导管原位癌进展的驱动因素?
Br J Cancer. 2022 Nov;127(10):1744-1754. doi: 10.1038/s41416-022-01885-5. Epub 2022 Jun 28.
2
Use of RNA-Seq and a Transgenic Mouse Model to Identify Genes Which May Contribute to Mutant p53-Driven Prostate Cancer Initiation.使用RNA测序和转基因小鼠模型来鉴定可能促成突变型p53驱动的前列腺癌起始的基因。
Biology (Basel). 2022 Jan 29;11(2):218. doi: 10.3390/biology11020218.
3
Mutant p53 Gain-of-Function: Role in Cancer Development, Progression, and Therapeutic Approaches.
突变型p53的功能获得:在癌症发生、发展及治疗方法中的作用
Front Cell Dev Biol. 2021 Feb 11;8:607670. doi: 10.3389/fcell.2020.607670. eCollection 2020.
4
Upregulation of fibronectin following loss of p53 function is a poor prognostic factor in ovarian carcinoma with a unique immunophenotype.p53 功能丧失后纤维连接蛋白的上调是具有独特免疫表型的卵巢癌的不良预后因素。
Cell Commun Signal. 2020 Jul 7;18(1):103. doi: 10.1186/s12964-020-00580-3.
5
Exogenous ERα Expression in the Mammary Epithelium Decreases Over Time and Does Not Contribute to p53-Deficient Mammary Tumor Formation in Mice.乳腺上皮细胞中内源性 ERα 的表达随时间推移而减少,并且不会促进 p53 缺陷型小鼠的乳腺肿瘤形成。
J Mammary Gland Biol Neoplasia. 2019 Dec;24(4):305-321. doi: 10.1007/s10911-019-09437-z. Epub 2019 Nov 15.
6
Somatic Trp53 mutations differentially drive breast cancer and evolution of metastases.体细胞 Trp53 突变差异驱动乳腺癌及其转移的演进。
Nat Commun. 2018 Sep 27;9(1):3953. doi: 10.1038/s41467-018-06146-9.
7
How do we fit ferroptosis in the family of regulated cell death?铁死亡如何融入调控性细胞死亡家族?
Cell Death Differ. 2017 Dec;24(12):1991-1998. doi: 10.1038/cdd.2017.149. Epub 2017 Oct 6.
8
Establishment of basal cell carcinoma animal model in Chinese tree shrew ().建立中华树鼩()基底细胞癌动物模型。
Zool Res. 2017 Jul 18;38(4):180-190. doi: 10.24272/j.issn.2095-8137.2017.045.
9
Osteosarcoma: Molecular Pathogenesis and iPSC Modeling.骨肉瘤:分子发病机制与诱导多能干细胞建模
Trends Mol Med. 2017 Aug;23(8):737-755. doi: 10.1016/j.molmed.2017.06.004. Epub 2017 Jul 20.
10
The DNA resection protein CtIP promotes mammary tumorigenesis.DNA切除蛋白CtIP促进乳腺肿瘤发生。
Oncotarget. 2016 May 31;7(22):32172-83. doi: 10.18632/oncotarget.8605.